The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients

References

1. ↵
   1. Alikhan R,
   2. Cohen AT

   Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction), Available from URL: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003747.pub2/abstract;jsessionid=9E9D8115F7F5A8F8A9B34D5AB9C5511A.f01t03. Cited 2009 July 8.
2. ↵
   1. Alhazzani W,
   2. Lim W,
   3. Jaeschke RZ,
   4. Murad MH,
   5. Cade J,
   6. Cook DJ

   (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41:2088–2098.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Amin AN,
   2. Girard F,
   3. Samama MM

   (2010) Does ambulation modify venous thromboembolism risk in acutely ill medical patients? Thromb Haemost 104:955–961.

   OpenUrlCrossRefPubMed
4. ↵
   1. Arabi YM,
   2. Khedr M,
   3. Dara SI,
   4. Dhar GS,
   5. Bhat SA,
   6. Tamim HM,
   7. et al.

   (2013) Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity scores adjusted analysis. Chest 144:152–159.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Cohen AT,
   2. Spiro TE,
   3. Buller HR,
   4. Haskell L,
   5. Hu D,
   6. Hull R,
   7. et al.

   (2013) Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 368:513–523.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Hirsch DR,
   2. Ingenito EP,
   3. Goldhaber SZ

   (1995) Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 274:335–337.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Kanaan AO,
   2. Silva MA,
   3. Donovan JL,
   4. Roy T,
   5. Al-Homsi AS

   (2007) Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Clin Ther 29:2395–2405.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Mismetti P,
   2. Laporte S,
   3. Darmon JY,
   4. Buchmuller A,
   5. Decousus H

   (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88:913–930.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Collaboration CT

   (2009) Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 373:1958–1965.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Cohen AT,
    2. Tapson VF,
    3. Bergmann JF,
    4. Goldhaber SZ,
    5. Kakkar AK,
    6. Deslandes B,
    7. et al.

    (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371:387–394.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Abo-El-Nazar Essam GS,
    2. Al-Hameed F

    (2011) Venous thromboembolism-related mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia. Ann Thorac Med 6:193–198.

    OpenUrlPubMed
12. ↵
    1. Kahn SR,
    2. Lim W,
    3. Dunn AS,
    4. Cushman M,
    5. Dentali F,
    6. Akl EA,
    7. et al.

    (2012) Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e195S–e226S.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Qaseem A,
    2. Chou R,
    3. Humphrey LL,
    4. Starkey M,
    5. Shekelle P

    (2011) Clinical Guidelines Committee of the American College of P. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 155:625–632.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Al-Hameed FM,
    2. Al-Dorzi HM,
    3. Abdelaal MA,
    4. Alaklabi A,
    5. Bakhsh E,
    6. Alomi YA,
    7. et al.

    Clinical Practice Guideline on Prophylaxis of VTE in Medical Patients and Long Distance Travelers, Available from URL: http://www.moh.gov.sa/endepts/Proofs/Pages/Guidelines.aspx. Update 2015; Accessed 2016 July 30.
15. ↵
    1. Schunemann HJ,
    2. Wiercioch W,
    3. Etxeandia I,
    4. Falavigna M,
    5. Santesso N,
    6. Mustafa R,
    7. et al.

    (2014) Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ 186:E123–E142.

    OpenUrlAbstract/FREE Full Text
16. ↵
    The Saudi Center for Evidence Based Healthcare (EBHC): Clinical Practice Guidelines, Available from URL: http://www.moh.gov.sa/endepts/Proofs/Pages/Guidelines.aspx. Cited 2015.
17. ↵
    1. Guyatt GH,
    2. Oxman AD,
    3. Vist GE,
    4. Kunz R,
    5. Falck-Ytter Y,
    6. Alonso-Coello P,
    7. et al.

    (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926.

    OpenUrlFREE Full Text
18. ↵
    1. GRADE Working Group

    GRADE guidelines - best practices using the GRADE framework, Available from URL: http://www.gradeworkinggroup.org/publications/JCE_series.htm. Cited 2011.
19. ↵
    1. Alonso-Coello P,
    2. Schunemann H,
    3. Moberg J,
    4. Brignardello-Petersen R,
    5. Akl E,
    6. Davoli M,
    7. Treweek S,
    8. Mustafa R,
    9. Rada G,
    10. Rosenbaum S,
    11. Morelli A,
    12. Guyatt GH,
    13. Oxman AD

    (2016) GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. BMJ 353:i2016.

    OpenUrlFREE Full Text
20. 1. Alonso-Coello P,
    2. Oxman AD,
    3. Moberg J,
    4. Brignardello-Petersen R,
    5. Akl E,
    6. Davoli M,
    7. Treweek S,
    8. Mustafa R,
    9. Vandvik P,
    10. Meerpohl J,
    11. Guyatt GH,
    12. Schunemann H

    (2016) GRADE Evidence to Decision frameworks: 2. Clinical practice guidelines. BMJ 353:i2089.

    OpenUrlFREE Full Text
21. ↵
    1. Schuenemann HJ,
    2. Mustafa R,
    3. Brozek J,
    4. Santesso N,
    5. alonso-Coello P,
    6. Guyatt G,
    7. et al.

    (Feb 27, 2016) Development of the GRADE Evidence to Decision (EtD) frameworks for tests in clinical practice and public health. J Clin Epidemiol, pii: S0895-4356(16)00136-0.
22. ↵
    1. World Health Organization

    WHO Handbook for Guideline Development: World Health Organization, Available from: http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf. Cited 2012.
23. ↵
    1. Schunemann H,
    2. Mustafa R,
    3. Brozek J,
    4. Carrasco-Labra A,
    5. Brignardello-Peterson R,
    6. Wiercioch W

    Saudi Arabian Handbook for Healthcare Guideline Development, Available from: http://www.moh.gov.sa/endepts/Proofs/Pages/GuidelineAdaptation.aspx. Cited 2014.
24. ↵
    1. Andrews J,
    2. Guyatt G,
    3. Oxman AD,
    4. Alderson P,
    5. Dahm P,
    6. Falck-Ytter Y,
    7. et al.

    (2013) GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66:719–725.

    OpenUrlCrossRefPubMed
25. ↵
    1. Barbar S,
    2. Noventa F,
    3. Rossetto V,
    4. Ferrari A,
    5. Brandolin B,
    6. Perlati M,
    7. et al.

    (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8:2450–2457.

    OpenUrlCrossRefPubMed
26. ↵
    1. Dentali F,
    2. Douketis JD,
    3. Gianni M,
    4. Lim W,
    5. Crowther MA

    (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 146:278–288.

    OpenUrlCrossRefPubMedWeb of Science
27. ↵
    1. Barbar S,
    2. Noventa F,
    3. Rossetto V,
    4. Ferrari A,
    5. Brandolin B,
    6. Perlati M,
    7. et al.

    (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. Journal of thrombosis and haemostasis. J Thromb Haemost 8:2450–2457.

    OpenUrlCrossRefPubMed
28. ↵
    1. Ishi SV,
    2. Lakshmi M,
    3. Kakde ST,
    4. Sabnis KC,
    5. Jagannati M,
    6. Girish T,
    7. et al.

    (2013) Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in thrombo-prophylaxis. J Assoc Physicians India 61:882–886.

    OpenUrl
29. ↵
    1. Sharma A,
    2. Chatterjee S,
    3. Lichstein E,
    4. Mukherjee D

    (2012) Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes? Journal of thrombosis and haemostasis. J Thromb Haemost 10:2053–2060.

    OpenUrlPubMed
30. ↵
    1. Muir K,
    2. Watt A,
    3. Baxter G,
    4. Grosset D,
    5. Lees K

    (2000) Randomized trial of graded compression stockings for prevention of deep vein thrombosis after acute stroke. QJM 93:359–364.

    OpenUrlCrossRefPubMed
31. ↵
    1. Roderick P,
    2. Ferris G,
    3. Wilson K,
    4. Halls H,
    5. Jackson D,
    6. Collins R,
    7. et al.

    (2005) Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 9:1–78.

    OpenUrlPubMed
32. ↵
    1. Sud S,
    2. Mittmann N,
    3. Cook DJ,
    4. Geerts W,
    5. Chan B,
    6. Dodek P,
    7. et al.

    (2011) Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med 184:1289–1298.

    OpenUrlCrossRefPubMed
33. ↵
    1. Anderson FA Jr.,
    2. Wheeler HB,
    3. Goldberg RJ,
    4. Hosmer DW,
    5. Forcier A,
    6. Patwardhan NA

    (1994) Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 154:669–677.

    OpenUrlCrossRefPubMedWeb of Science
34. ↵
    1. Al-Hameed F,
    2. Al-Dorzi HM,
    3. Aboelnazer E

    (2014) The effect of a continuing medical education program on Venous thromboembolism prophylaxis utilization and mortality in a tertiary-care hospital. Thromb J 12:9.

    OpenUrlCrossRefPubMed
35. ↵
    1. Scaglione L,
    2. Piobbici M,
    3. Pagano E,
    4. Ballini L,
    5. Tamponi G,
    6. Ciccone G

    (2005) Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica 90:678–684.

    OpenUrlAbstract/FREE Full Text
36. 1. Cohn SL,
    2. Adekile A,
    3. Mahabir V

    (2006) Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention. J Hosp Med 1:331–338.

    OpenUrlCrossRefPubMed
37. 1. Gallagher M,
    2. Oliver K,
    3. Hurwitz M

    (2009) Improving the use of venous thromboembolism prophylaxis in an Australian teaching hospital. Qual Saf Health Care 18:408–412.

    OpenUrlAbstract/FREE Full Text
38. 1. Al-Tawfiq JA,
    2. Saadeh BM

    (2011) Improving adherence to venous thromoembolism prophylaxis using multiple interventions. Ann Thorac Med 6:82–84.

    OpenUrlPubMed
39. ↵
    1. Tooher R,
    2. Middleton P,
    3. Pham C,
    4. Fitridge R,
    5. Rowe S,
    6. Babidge W,
    7. et al.

    (2005) A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 241:397–415.

    OpenUrlCrossRefPubMedWeb of Science